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S U M M A R Y   
A 20 year old lady presented to the acute medical unit with new neurological deficits. She described gastroin-
testinal symptoms in the preceding 24 hours. Her case was discussed with infectious diseases and neurology 
overnight, both of whom were resident at a hospital on the other side of the city. The infectious diseases team 
were concerned enough to discuss the case with Public Health England for consideration of botulism antitoxin. 
When this diagnosis was discounted on the basis of asymmetric neurological deficits, the patient was admitted 
under the care of the neurologists. Mononeuritis multiplex of unclear aetiology was diagnosed. A subsequent 
infectious diseases review resulted in a diagnosis of primary EBV infection, the likely trigger of the symptoms. 
Whilst neurologic deficits resolved, neuropathic pain continues. Learning points include the importance of an 
early, accurate description of neurologic deficits and the need to consider EBV as an infectious trigger of 
mononeuritis multiplex. Collaboration between neurology and infectious disease physicians was key in managing 
this patient and disentangling the broad array of infectious and non-infectious differential diagnoses.   
Background 
Although primary EBV infection is common, neurological sequelae 
are seldom encountered. The presence of gastrointestinal symptoms in 
this case led away from the eventual diagnosis, and stimulated an 
overnight discussion with Public Health England about acquiring 
botulism antitoxin. Patients presenting with rapidly progressing 
neurological deficits present a diagnostic conundrum that must be dis-
entangled quickly in case specific treatments are required to prevent 
progression. This case reinforces the value of an objective neurological 
examination undertaken by an experienced clinician, and the success of 
collaboration between infection and neurology physicians in reaching a 
diagnosis. 
Case presentation 
A 20 year old female student presented to the emergency department 
having found it difficult to walk, such that she had fallen and chipped 
her tooth. She described two episodes of loose stool and several vomits 
within the preceding 24 h. An erythematous rash had developed over the 
internal aspect of her left elbow, right anterior shin and left knee. 
The patient had not travelled in the preceding twelve months and 
had spent some of her childhood in Australia, returning to the UK ten 
years previously. There was no history of tick bites or recent walking 
holidays. There was no history of consuming food past its expiration 
date, undercooked food or food that had been canned/pickled at home. 
Examination findings were initially described as purely motor, 
affecting the left arm and right leg with a left ptosis. As the night pro-
gressed the receiving medical team discussed the case with the 
neurology/infectious disease registrars who were based at a different 
site within the same hospital trust. These discussions suggested pro-
gression of the deficits, prompting the infectious diseases registrar to 
telephone his consultant to discuss the faint, but not-to-be-missed, 
prospect of food borne botulism. There was sufficient concern to esca-
late the discussion to the on call Public Health England consultant, who 
in turn spoke with a colleague specialising in botulism. The case was de- 
escalated on the basis of asymmetric neurologic deficits, inconsistent the 
symmetric deficits associated with botulism. A single dose of intrave-
nous ceftriaxone was given to cover for neuroborreliosis. 
The patient was admitted to neurology, where examination revealed 
a left miosis and partial ptosis, attributed to damage to the para-
sympathetic outer fibres and the somatic inner fibres of the oculomotor 
nerve, respectively. Left ulnar distribution paraesthesia, and left ulnar 
myotome weakness were present, resulting in a positive Froment’s sign. 
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There was right common peroneal nerve distribution weakness resulting 
in right foot drop, with associated paraesthesia over the right lateral 
heel, posterior aspect of the lower leg and popliteal fossa. Erythema was 
noted over the medial aspect of the left elbow, right anterior shin and 
left anterior knee. A clinical diagnosis of mononeuritis multiplex was 
made. The infectious diseases team were asked to review the patient to 
investigate for an infectious trigger. 
Investigations 
A neutrophil leucocytosis of 17.06 × 109/L and monocytosis of 1.09 
× 109/L were noted on admission bloods, alongside a transaminitis (ALT 
108 IU/L, reference 0–33). C reactive protein was elevated at 61 mg/L 
(reference 0–5). A vasculitic screen and autoimmune panel were unre-
markable. Cerebrospinal fluid (CSF) contained a low white cell count (2 
× 106/L), normal protein (0.25 g/L) and yielded no organisms on cul-
ture. CSF PCR was negative for Herpes Simplex, Varicella Zoster and 
Enterovirus. 
Imaging consisted of a plain chest radiograph, an abdominal ultra-
sound, and MRI brain/whole spine with contrast. These studies were 
unremarkable. 
Nerve conduction studies performed 6 days after presentation 
demonstrated proximal pathology of the left ulnar nerve consistent with 
early mononeuritis multiplex. No clear abnormalities in nerve conduc-
tion were seen within the symptomatic right leg, with a comment made 
that pathology in the early stages of evolution might not yet be apparent. 
SARS CoV-2 PCR and a multiplex PCR panel for seasonal respiratory 
viruses were negative. There was no serological evidence of past or 
present infection with viral hepatitides (including hepatitis A and E), 
Human Immunodeficiency Virus, Borrelia, syphilis or Cytomegalovirus. 
Anti-streptolysin O titre was not elevated. 
EBV IgM antiviral capsid antigen (VCA) antibodies were detected, 
alongside weakly positive EBV VCA IgG antibodies. Ebstein Barr nuclear 
antigen (EBNA) IgG antibody was not detected. EBV DNA was detected 
in blood at 2.85 log copies/ml (707 copies/ml). The serology and PCR 
results are suggestive of recent acute primary EBV infection. 
Serology was repeated eight weeks later: although VCA IgM was still 
present, this was at a lower index. The VCA IgG was detected at a higher 
index. EBNA IgG was not detected. Although reactivated EBV infection 
could have caused a low level viraemia, our clinical judgement is that 
the sero-evolution is in support of a diagnosis of recent acute primary 
EBV. EBNA IgG positivity may develop in time (Table 1.) 
Differential diagnosis 
Acute onset neurologic deficits in a young patient carry a wide dif-
ferential diagnosis. Given the gastrointestinal symptoms foodborne 
botulism was considered early on. This condition requires rapid treat-
ment with botulism antitoxin, which is only available from the Colindale 
Public Health England site. As the story unfolded, it transpired that the 
deficits were both motor and sensory and asymmetric, making this 
diagnosis unlikely. This enabled de-escalation following expert 
discussion. 
Vasculitic neuropathies causing this presentation without an 
established diagnosis of a systemic vasculitis were dismissed after vas-
culitic screen and autoimmune panel came back unremarkable. 
Neuroborreliosis can present with cranial nerve deficits and motor/ 
sensory radiculopathies (Schwenkenbecher et al., 2017). This diagnosis 
was considered, but lack of epidemiologic exposure made it unlikely. 
This was later confirmed by negative Borrelia serology. The Miller Fisher 
variant of Guillan-Barré was also considered, but the neurologic deficits 
fortunately did not progress and only one eye was implicated, making 
this less likely. 
Other infectious precipitants of mononeuritis include hepatitis A, B, 
C and E, parvovirus B-19, Herpes simplex virus, HIV, Cytomegalovirus 
and leprosy (Lenglet et al., 2011; SathiSh Pai and Pai, 2013; Palma et al., 
2018). 
Treatment 
Intravenous ceftriaxone was administered to cover neuroborreliosis, 
but later discontinued on the basis of lack of epidemiologic exposure. 
Otherwise treatments were supportive, consisting of paracetamol and 
codeine for neuralgic pains. 
Outcome and follow-up 
After two months motor and sensory deficits have almost entirely 
resolved. The patient still has neuropathic pain in the ulnar sensory 
distribution of her hand and the sole of her right foot. She also reports 
uneven pupils occasionally and a droopy left eyelid. 
Discussion 
Epstein-Barr Virus (EBV) is a human herpes virus spread predomi-
nantly through shared saliva (Fafi-Kremer et al., 2005). In a seropre-
valence study in England, more than half of 11 year olds showed 
evidence of past infection, rising to 93% of 22–24 year olds (Winter 
et al., 2019). Often asymptomatic in children, primary EBV infection in 
adolescents and adults may give rise to ‘infectious mononucleosis’, 
characterised by fever, lymphadenopathy and pharyngitis (Cohen, 
2000). Complications including airway obstruction, meningo- 
encephalitis, haemolytic anaemia, thrombocytopaenia and rash 
(particularly in association with penicillin administration) occur with a 
frequency greater than one percent. An array of rarer complications 
occur with a frequency less than one percent, and include pneumonitis, 
myocarditis, pancreatitis, and parotitis (Odumade et al., 2011). 
Neurologic complications of primary EBV infection have been 
described including brachial plexopathy (Dodig, 2010) facial palsy 
(Diedler et al., 2006) sensory neuropathy (Rubin and Daube, 1999) and 
optic neuritis (Corssmit et al., 1997). Mononeuritis multiplex has been 
described in a small number of case reports, the first of which reported 
possible recrudescence of a past infection (Corssmit et al., 1997) one in 
association with cryoglobulinaemia (Villeneuve et al., 2016) and once 
case from 1974 associated with a positive Paul-Bunnel test (Liveson and 
Goodgold, 1974). Nerve damage due to viral infection is thought to be 
mediated by one of two mechanisms: direct damage by the virus, or 
secondary immune mediated para infectious damage (Pezzini and 
Padovani, 2020). In Guillan Barré syndrome, which may be triggered by 
another human herpes virus (Cytomegalovirus), a phenomenon of mo-
lecular mimicry occurs, whereby the immune response to the virus cross 
reacts with epitopes on peripheral nerves (Yuki and Hartung, 2012). It is 
feasible that a similar mechanism may underlie nerve damage associated 
with EBV, although we are not aware of any experimental evidence to 
support this. Therapies such as intravenous immunoglobulins or steroids 
might play a role in modifying this pathophysiology, but this is purely 
speculative. 
EBV serology is notoriously difficult to interpret. During acute 
infection the virus is in a lytic phase and this is associated with 
expression of viral capsid antigens (VCA). Usually IgM VCA antibodies 
Table 1 
Anticipated serologic and virologic findings in primary, established, and reac-
tivated EBV infection. VCA = Viral Capsid Antigen; EBNA = Epstein Barr Virus 
Nuclear Antigen.   
Primary 
Infection 
Past infection Reactivated 
infection 
VCA IgM Present Absent Present or absent 
VCA IgG Present or absent Present Present 
EBNA IgG Absent Present in most cases Present or absent 
EBV viraemia Present Absent Present  
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develop in early infection, followed by IgG VCA antibodies. Over coming 
weeks IgM VCA antibody titres wane, but can be detectable for several 
months (De Paschale, 2012). Once acute infection has resolved the virus 
establishes latency. This is associated with the expression of EBV nuclear 
antigens (EBNA), resulting in detectable EBNA IgG. Approximately 5% 
of patients do not develop EBNA antibodies (De Paschale et al., 2009). 
Reactivated infection can be associated with the presence of VCA IgM 
and IgG alongside EBNA IgG (Table 1). 
In this case the detection of VCA IgM and IgG, alongside a low level 
viraemia, was indicative of recent past infection. Sero-evolution helped 
to confirm the diagnosis, with titres of IgM VCA falling after eight weeks. 
The titres of VCA IgG increased after 8 weeks. EBNA IgG was not 
detected. This could be because it was too early after the acute infection; 
it is also possible that EBNA IgG will never develop in this patient. CSF 
PCR for EBV was not undertaken in this case. Although the rarity of this 
presentation means that it is uncertain whether EBV might be detected 
in CSF with mononeuritis, the test would have been of interest, whether 
positive or negative. 
Learning points  
• Neurologic complications can follow primary EBV infection, although 
these are rare. EBV should be considered as a precipitant of unexplained 
mononeuritis multiplex.  
• EBV serology requires careful interpretation, and it is often necessary to 
repeat serology at a later date to demonstrate evolution of antibody re-
sponses and confirm the diagnosis.  
• Neurologic deficits can be triggered by a wide range of infections. An 
assiduous neurological examination, repeated over time, is necessary to 
inform the differential diagnosis.  
• Neurologists and infection doctors have complementary skill sets, which 
work well in the investigation and management of such patients 
Patient’s perspective 
“ My right pupil was much larger than the left 
I had a dreadful headache behind my right eye. 
I had nausea and vomiting, difficulty keeping food down. 
I was unable to see clearly to read, and subsequently require 
spectacles. 
It was all very frightening, especially as nobody knew why it was 
happening, but all of the staff were so lovely and reassuring. 
I still have unequal pupils occasionally, and the drooping of my left 
eye. 
I get occasional numbness in my right foot and left hand; I have fallen 
down the stairs twice. 
I get occasional nausea and diarrhoea, although the headaches seem 
to have disappeared. 
I have stopped amitriptyline, and just get occasional pain in my foot. 
Will this happen to me again? ” 
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